Dannex Ayrton Starwin Plc

Dannex Ayrton Starwin Plc (DAS Plc) was established in December 2019 as a result of a successful merger of Dannex Limited, Ayrton Drug Manufacturing Limited and Starwin Products Limited. The company was subsequently listed on the Ghana Stock Exchange on January 15, 2020 under the acronym DASPHARMA. The creation of DAS Plc is significant, as never in the annals of business history in Ghana has there been a merger of three indigenous companies. The merged entity is poised to become the largest pharmaceutical manufacturing company in Ghana, with a range of 80 plus products and a staff strength of over 600. Some of these products have been household names in Ghana since the 1960’s and continue to be effective today. These include Durol, ORS, Teeder, Starwin Milk of Magnesia, Samalin and Rapinol. DAS Plc’s market share will increase as a result of the merger, through an accelerated growth programme to yield an expanded customer base. DAS Plc would leverage such synergies for improved efficiency in its operations that would benefit greatly from economies of scale. The company would aggressively pursue exports into the West African market and beyond with it’s increased product range and optimized operational efficiency. It is further anticipated that synergies created would yield attractive returns for shareholders as well as the investing public. Consumers and the general public would benefit greatly from the quality and affordability associated with such a great Ghanaian company.